Cargando…
New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090473/ https://www.ncbi.nlm.nih.gov/pubmed/33934589 http://dx.doi.org/10.3803/EnM.2021.203 |
| _version_ | 1783687291955314688 |
|---|---|
| author | Jung, Chan-Hee |
| author_facet | Jung, Chan-Hee |
| author_sort | Jung, Chan-Hee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8090473 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80904732021-05-11 New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors Jung, Chan-Hee Endocrinol Metab (Seoul) Editorial Korean Endocrine Society 2021-04 2021-04-27 /pmc/articles/PMC8090473/ /pubmed/33934589 http://dx.doi.org/10.3803/EnM.2021.203 Text en Copyright © 2021 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Jung, Chan-Hee New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title | New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title_full | New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title_fullStr | New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title_full_unstemmed | New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title_short | New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors |
| title_sort | new era for renal-protective therapy in type 2 diabetes: better renal outcomes in patients with type 2 diabetes taking sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090473/ https://www.ncbi.nlm.nih.gov/pubmed/33934589 http://dx.doi.org/10.3803/EnM.2021.203 |
| work_keys_str_mv | AT jungchanhee neweraforrenalprotectivetherapyintype2diabetesbetterrenaloutcomesinpatientswithtype2diabetestakingsodiumglucosecotransporter2inhibitorsversusdipeptidylpeptidase4inhibitors |